This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.

The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.

Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.

By accessing this website you accept this legal notice and expressly confirm your status as a healthcare professional.

Brigham and Women’s Hospital & Harvard Medical School, Boston, USA

Erin Bohula is an Associate Physician in Cardiovascular Medicine at Brigham and Women’s Hospital, Boston, MA, USA, an Investigator at the Thromboloysis in Myocardial Infarction Clinical Trials (TIMI) Study Group and an Assistant Professor at Harvard Medical School. Dr Bohula earned her DPhil in Molecular Biology from University of Oxford, Oxford, UK on a Rhodes Scholarship and her medical degree from Harvard Medical School, Boston, MA. Following training at the Brigham and Women’s Hospital, she received board certification in internal medicine, cardiology, and critical care medicine.


In her role as a TIMI Study Group Investigator, Dr Bohula studies pharmacologic interventions for cardiometabolic diseases, such as hyperlipidaemia, obesity and atherosclerotic cardiovascular disease. As a cardiac intensivist and researcher, she is interested in innovative therapies and devices for critically ill cardiovascular patients and was involved in creating the Critical Care Cardiology Trials Network, a North American research collaborative of cardiology critical care units (CICU). She was the recipient of the Eugene Braunwald Cardiovascular Medicine Physician Scientist Scholar Award in 2018 and the W. Proctor Harvey MD Young Teacher Award from the ACC in 2017.